Skip to main content

Advertisement

Log in

Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant

  • Health Economics (N Khera, Section Editor)
  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Individuals diagnosed with hematologic malignancies experience significant unmet psychological, physical, informational, financial, and spiritual needs. The goal of the current review is to summarize and highlight recent research focused on these issues in the diagnosis and treatment periods and beyond. The review also describes the needs of adolescent and young adult (AYA) and pediatric patients. While a large body of research has reported on unmet needs among adult hematologic cancer patients, there is far less data regarding the challenges confronted by AYA and pediatric populations. Available data suggests that among all age groups, hematopoietic cell transplantation (HCT) is a risk factor for greater unmet needs. Recommendations for screening and evidence-based interventions to prevent or ameliorate unmet needs are provided. Future research is needed to develop additional evidence-based psychosocial interventions with a focus on hematologic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Boyes AW et al. Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy. Acta Oncol. 2015;54:507–14. This is a recent, large study of unmet needs among hematologic cancer patients.

    Article  PubMed  Google Scholar 

  2. Hall A et al. Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study. Support Care Cancer. 2014;22:2899–909.

    Article  PubMed  Google Scholar 

  3. Lobb EA et al. When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77:103–8.

    Article  CAS  PubMed  Google Scholar 

  4. Armes J et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9.

    Article  PubMed  Google Scholar 

  5. Jim HS et al. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer. 2016;122:1290–7.

    Article  PubMed  Google Scholar 

  6. Sarkar S et al. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:1217–22.

    Article  CAS  PubMed  Google Scholar 

  7. Hoodin F et al. Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2013;19:1493–7.

    Article  PubMed  Google Scholar 

  8. Hefner J et al. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. Bone Marrow Transplant. 2014;49:581–4.

    Article  CAS  PubMed  Google Scholar 

  9. El-Jawahri AR et al. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer. 2016;122:806–12.

    Article  PubMed  Google Scholar 

  10. Phillips KM et al. Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer. 2013;21:1097–103.

    Article  PubMed  Google Scholar 

  11. Gheihman G et al. Depression and hopelessness in patients with acute leukemia: the psychological impact of an acute and life-threatening disorder. Psychooncology. 2015. doi:10.1002/pon.3940.

    PubMed  Google Scholar 

  12. Zimmermann C et al. Symptom burden and supportive care in patients with acute leukemia. Leuk Res. 2013;37:731–6.

    Article  PubMed  Google Scholar 

  13. Pulgar A, Alcala A, Reyes Del Paso GA. Psychosocial predictors of quality of life in hematological cancer. Behav Med. 2015;41:1–8.

    Article  PubMed  Google Scholar 

  14. Horsboel TA et al. Are fatigue, depression and anxiety associated with labour market participation among patients diagnosed with haematological malignancies? A prospective study. Psychooncology. 2015;24:408–15.

    Article  PubMed  Google Scholar 

  15. Mumby PB et al. Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplant. 2012;47:556–61.

    Article  CAS  PubMed  Google Scholar 

  16. Prieto JM et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907–17.

    Article  PubMed  Google Scholar 

  17. Loberiza Jr FR et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2118–26.

    Article  PubMed  Google Scholar 

  18. Pillay B et al. Psychosocial factors predicting survival after allogeneic stem cell transplant. Support Care Cancer. 2014;22:2547–55.

    Article  PubMed  Google Scholar 

  19. Bevans M et al. Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology. 2011;20:615–22.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wood WA et al. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013;19:450–9.

    Article  PubMed  Google Scholar 

  21. DuHamel KN et al. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol. 2010;28:3754–61.

    Article  PubMed  PubMed Central  Google Scholar 

  22. David N et al. Internet-based program for coping with cancer: a randomized controlled trial with hematologic cancer patients. Psychooncology. 2013;22:1064–72.

    Article  CAS  PubMed  Google Scholar 

  23. Applebaum AJ et al. Therapeutic alliance in telephone-administered cognitive-behavioral therapy for hematopoietic stem cell transplant survivors. J Consult Clin Psychol. 2012;80:811–6.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Niederbacher S et al. Patients’ quality of life after allogeneic haematopoietic stem cell transplantation: mixed-methods study. Eur J Cancer Care (Engl). 2012;21:548–59.

    Article  CAS  Google Scholar 

  25. Jim HS et al. Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life. Bone Marrow Transplant. 2014;49:299–303.

    Article  CAS  PubMed  Google Scholar 

  26. Korszun A et al. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors. Br J Haematol. 2014;164:790–803.

    Article  PubMed  Google Scholar 

  27. Kekale M, Peltoniemi M, Airaksinen M. Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment. Patient Prefer Adherence. 2015;9:1733–40.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Grulke N, Albani C, Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant. 2012;47:473–82.

    Article  CAS  PubMed  Google Scholar 

  29. Braamse AM et al. Developing a risk prediction model for long-term physical and psychological functioning after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:549–56.

    Article  PubMed  Google Scholar 

  30. Phillips KM et al. A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:1350–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Persoon S et al. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39:682–90.

    Article  PubMed  Google Scholar 

  32. van Haren IE et al. Physical exercise for patients undergoing hematopoietic stem cell transplantation: systematic review and meta-analyses of randomized controlled trials. Phys Ther. 2013;93:514–28.

    Article  PubMed  Google Scholar 

  33. Lawrence JA et al. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv. 2016;10:176–84.

    Article  CAS  PubMed  Google Scholar 

  34. Jean-Pierre P et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer. 2010;116:3513–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gong S et al. Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One. 2014;9:e84391.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Rood JA et al. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences. Hematol Oncol. 2015;33:85–98.

    Article  PubMed  Google Scholar 

  37. Alexander SC et al. Information giving and receiving in hematological malignancy consultations. Psychooncology. 2012;21:297–306.

    Article  PubMed  Google Scholar 

  38. Montgomery C et al. Predicting psychological distress in patients with leukaemia and lymphoma. J Psychosom Res. 2003;54:289–92.

    Article  PubMed  Google Scholar 

  39. Efficace F et al. Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer. 2012;107:904–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Maher M et al. A novel health information technology communication system to increase caregiver activation in the context of hospital-based pediatric hematopoietic cell transplantation: a pilot study. JMIR Res Protoc. 2015;4:e119.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Horne B et al. Development and evaluation of a specifically designed website for haematopoietic stem cell transplant patients in Leeds. Eur J Cancer Care (Engl). 2015. doi:10.1111/ecc.12352.

    Google Scholar 

  42. Stienen JJ et al. Development and evaluation of an educational e-tool to help patients with non-Hodgkin’s lymphoma manage their personal care pathway. JMIR Res Protoc. 2015;4:e6.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Syrjala KL et al. Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. J Cancer Surviv. 2011;5:292–304.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Huntington SF et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2:e408–16.

    Article  PubMed  Google Scholar 

  45. Dusetzina SB et al. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32:306–11.

    Article  PubMed  Google Scholar 

  46. Khera N et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20:1375–81.

    Article  PubMed  Google Scholar 

  47. Kim W et al. Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient’s perspective. Bone Marrow Transplant. 2015;50:1259–61.

    Article  CAS  PubMed  Google Scholar 

  48. Stepanikova I et al. Exploring long-term cancer survivors’ experiences in the career and financial domains: Interviews with hematopoietic stem cell transplantation recipients. J Psychosoc Oncol. 2016;34:2–27.

    Article  PubMed  Google Scholar 

  49. Silla L et al. Patient socioeconomic status as a prognostic factor for allo-SCT. Bone Marrow Transplant. 2009;43:571–7.

    Article  CAS  PubMed  Google Scholar 

  50. Jim HS, Jacobsen PB. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J. 2008;14:414–9.

    Article  PubMed  Google Scholar 

  51. Tallman B et al. Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: a nine-year longitudinal study. Rehabil Psychol. 2010;55:204–10.

    Article  PubMed  Google Scholar 

  52. Leeson LA et al. Spirituality and the recovery of quality of life following hematopoietic stem cell transplantation. Health Psychol. 2015;34:920–8.

    Article  PubMed  Google Scholar 

  53. Prince P et al. Spiritual well-being in Hispanic and non-Hispanic survivors of allogeneic hematopoietic stem cell transplantation. J Psychosoc Oncol. 2015;33:635–54.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Pereira DB et al. Spiritual absence and 1-year mortality after hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2010;16:1171–9.

    Article  PubMed  Google Scholar 

  55. Breitbart W et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol. 2015;33:749–54.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Warner EL et al. Social well-being among adolescents and young adults with cancer: a systematic review. Cancer. 2016;122:1029–37.

    Article  PubMed  Google Scholar 

  57. Bellizzi KM et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118:5155–62.

    Article  PubMed  Google Scholar 

  58. Potosky AL, et al. Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst. 2014;106. doi: 10.1093/jnci/dju300.

  59. Geue K et al. Gender-specific quality of life after cancer in young adulthood: a comparison with the general population. Qual Life Res. 2014;23:1377–86.

    Article  PubMed  Google Scholar 

  60. Prasad PK et al. Psychosocial and neurocognitive outcomes in adult survivors of adolescent and early young adult cancer: A report from the childhood cancer survivor Study. J Clin Oncol. 2015;33:2545–52.

    Article  PubMed  Google Scholar 

  61. Ness KK et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol. 2013;31:4496–503.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kent EE et al. Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer. J Adolesc Young Adult Oncol. 2013;2:44–52.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Parsons HM et al. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012;30:2393–400.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Guy Jr GP et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood). 2014;33:1024–31.

    Article  Google Scholar 

  65. Kent EE et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710–7.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Dyer G et al. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Br J Haematol. 2016;172:592–601.

    Article  PubMed  Google Scholar 

  67. Halliday LE, Boughton MA, Kerridge I. Liminal reproductive experiences after therapies for hematological malignancy. Qual Health Res. 2015;25:408–16.

    Article  PubMed  Google Scholar 

  68. Joshi S et al. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014;49:477–84. This article provides important recommendations regarding fertility preservation for pediatric and AYA HCT recipients.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Keegan TH et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6:239–50.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Muffly LS et al. Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016;122:954–61.

    Article  PubMed  Google Scholar 

  71. Mattson MR, Demshar RK, Daly BJ. Quality of life of young adult survivors of hematologic malignancies. Cancer Nurs. 2013;36:E1–7.

    Article  PubMed  Google Scholar 

  72. Rabin C et al. Intervention format and delivery preferences among young adult cancer survivors. Int J Behav Med. 2013;20:304–10.

    Article  PubMed  Google Scholar 

  73. Perales MA, et al. Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Curr Hematol Malig Rep. 2016. [Epub ahead of print]. This article provides useful social media resources for AYA cancer patients.

  74. Richter D et al. Psychosocial interventions for adolescents and young adult cancer patients: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2015;95:370–86.

    Article  PubMed  Google Scholar 

  75. Smith AW et al. Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future. Cancer. 2016;122:988–99.

    Article  PubMed  Google Scholar 

  76. Nass SJ et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist. 2015;20:186–95. This article provides a summary of the current state of the science regarding the needs of AYA cancer patients.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Badr H et al. Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer. J Cancer Surviv. 2013;7:523–34.

    Article  PubMed  Google Scholar 

  78. Compas BE et al. Children and adolescents coping with cancer: self- and parent reports of coping and anxiety/depression. Health Psychol. 2014;33:853–61.

    Article  PubMed  PubMed Central  Google Scholar 

  79. van der Geest IM et al. Emotional distress in 652 Dutch very long-term survivors of childhood cancer, using the hospital anxiety and depression scale (HADS). J Pediatr Hematol Oncol. 2013;35:525–9.

    Article  PubMed  Google Scholar 

  80. Chang G et al. Children’s psychological distress during pediatric HSCT: parent and child perspectives. Pediatr Blood Cancer. 2012;58:289–96.

    Article  PubMed  Google Scholar 

  81. Bingen K et al. A multimethod assessment of psychosocial functioning and late effects in survivors of childhood cancer and hematopoietic cell transplant. J Pediatr Hematol Oncol. 2012;34:22–8.

    Article  PubMed  Google Scholar 

  82. Cox CL, et al. The unmet emotional, care/support, and informational needs of adult survivors of pediatric malignancies. J Cancer Surviv. 2016. [Epub ahead of print].

  83. Zeltzer LK et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2396–404.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Liu YM, et al. Quality of life after hematopoietic stem cell transplantation in pediatric survivors: comparison with healthy controls and risk factors. Cancer Nurs. 2016. [Epub ahead of print].

  85. Stuber ML et al. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010;125:e1124–34.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Seitz DC et al. Efficacy of an internet-based cognitive-behavioral intervention for long-term survivors of pediatric cancer: a pilot study. Support Care Cancer. 2014;22:2075–83.

    Article  PubMed  Google Scholar 

  87. van Dijk-Lokkart EM et al. Effects of a combined physical and psychosocial intervention program for childhood cancer patients on quality of life and psychosocial functioning: results of the QLIM randomized clinical trial. Psychooncology. 2015. doi:10.1002/pon.4016.

    Google Scholar 

  88. Kazak AE et al. Screening for psychosocial risk in pediatric cancer. Pediatr Blood Cancer. 2012;59:822–7.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Cox CL et al. Development of a comprehensive health-related needs assessment for adult survivors of childhood cancer. J Cancer Surviv. 2013;7:1–19.

    Article  PubMed  Google Scholar 

  90. Children’s Oncology Group. Long Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer v. 4. 2013. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf. Accessed 17 Mar 2016. This website provides important follow-up screening guidelines for pediatric and AYA cancer patients.

  91. Miller E, Jacob E, Hockenberry MJ. Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncol Nurs Forum. 2011;38:E382–93.

    Article  PubMed  Google Scholar 

  92. Mulrooney DA et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep. 2008;31:271–81.

    PubMed  PubMed Central  Google Scholar 

  93. Mulrooney DA et al. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. Cancer. 2008;112:2071–9.

    Article  PubMed  Google Scholar 

  94. Armenian SH et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118:1413–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Clanton NR et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117:2559–68.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Robinson KE et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer. 2010;54:585–90.

    PubMed  PubMed Central  Google Scholar 

  97. Willard VW et al. Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation. J Clin Oncol. 2014;32:3982–8.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Nazari S et al. Emotional/Behavioral problems in children with acute lymphoblastic leukemia: a case-control study. Int J Hematol Oncol Stem Cell Res. 2014;8:14–20.

    PubMed  PubMed Central  Google Scholar 

  99. Schultz KA et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2007;25:3649–56.

    Article  PubMed  Google Scholar 

  100. Kirchhoff AC et al. Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Med Care. 2010;48:1015–25.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Pelletier W, Bona K. Assessment of financial burden as a standard of care in pediatric oncology. Pediatr Blood Cancer. 2015;62 Suppl 5:S619–31.

    Article  PubMed  Google Scholar 

  102. Petridou ET et al. Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann Oncol. 2015;26:589–97.

    Article  CAS  PubMed  Google Scholar 

  103. Bona K et al. Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000–2010). Pediatr Blood Cancer. 2016;63:1012–8.

    Article  PubMed  Google Scholar 

  104. Kirchhoff AC et al. Supplemental security income and social security disability insurance coverage among long-term childhood cancer survivors. J Natl Cancer Inst. 2015;107:djv057.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Bona K et al. Trajectory of material hardship and income poverty in families of children undergoing chemotherapy: a prospective cohort study. Pediatr Blood Cancer. 2016;63:105–11.

    Article  PubMed  Google Scholar 

  106. Donovan KA, Jacobsen PB. Progress in the implementation of NCCN guidelines for distress management by member institutions. J Natl Compr Canc Netw. 2013;11:223–6.

    PubMed  Google Scholar 

  107. Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract. 2014;10:e368–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heather S. L. Jim.

Ethics declarations

Conflict of Interest

Anna Barata, William A. Wood, Sung Won Choi, and Heather S.L. Jim each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Health Economics

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barata, A., Wood, W.A., Choi, S.W. et al. Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant. Curr Hematol Malig Rep 11, 280–287 (2016). https://doi.org/10.1007/s11899-016-0328-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-016-0328-z

Keywords

Navigation